Urovant Sciences to Present Late-Breaking Data on Vibegron During Plenary Session at the American Urological Association Annual Meeting
IRVINE, Calif. & BASEL, Switzerland--(BUSINESS WIRE)--Apr 29, 2019--Urovant Sciences (Nasdaq: UROV), a clinical-stage biopharmaceutical company focused on developing and commercial…
